Fabry

Cardiovascular disease is the leading cause of death in Fabry disease patients.¹ Undiagnosed and untreated Fabry disease leads to progressive, irreversible, life-threatening heart injury.^2,3

Fabry disease is an X-linked lysosomal storage disease due to a defect in the gene encoding the lysosomal enzyme alpha-galactosidase A (α-Gal A), causing progressive cellular accumulation of the substrate globotriaosylceramide (GL-3) and globo-triaosylsphingosine (lyso-GL-3).

Think Fabry, think timely testing first.

Think Fabry, think screening at-risk family members.¹

Think Fabry, think regular profile-based assessments.

Dans les prochaines minutes, vous pouvez découvrir pourquoi le Lyso-Gl-3 est une aide précieuse pour étayer le diagnostic de la maladie de Fabry tant chez les hommes que chez les femmes.

A podcast series designed by cardiologists, for cardiologists and other healthcare professionals.